cholesterol: 26 double-blind, randomized, active, or placebo-controlled...

In metapack: Bayesian Meta-Analysis and Network Meta-Analysis

26 double-blind, randomized, active, or placebo-controlled clinical trials on patients with primary hypercholesterolemia sponsored by Merck & Co., Inc., Kenilworth, NJ, USA.

Description

A data set containing clinical trial on hypercholesterolemia including 26 trials and 2 treatment arms each, and other attributes of the participants

Usage

data(cholesterol)

Format

A data frame with 52 rows and 19 variables

study

study identifier

trial

trial identifier

treat

treatment indicator for Statin or Statin+Ezetimibe

n

the number of participants in the study arms corresponding to the trial and treatment

pldlc

aggregate percentage change in LDL-C

phdlc

aggregate percentage change from baseline in HDL-C

ptg

aggregate percentage change from baseline in triglycerides (TG)

sdldl

sample standard deviation of percentage change in LDL-C

sdhdl

sample standard deviation of percentage change in HDL-C

sdtg

sample standard deviation of percentage change in triglycerides (TG)

onstat

whether the participants were on Statin prior to the trial

bldlc

baseline LDL-C

bhdlc

baseline HDL-C

btg

baseline triglycerides (TG)

age

age in years

white

the proportion of white participants

male

the proportion of male participants

dm

the proportion of participants with diabetes mellitus

durat

duration in weeks

Examples

data(cholesterol)

metapack documentation built on May 31, 2022, 1:05 a.m.